Molecular Imaging Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the global Molecular Imaging Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
The molecular imaging market encompasses advanceed biomedical imaging techniques that enable healthcare professionals to visualize, characterize, and quantify biological processes at the cellular and molecular levels within living organisms. These technologies, including positron emission tomography (PET), single photon emission computed tomography (SPECT), and molecular ultrasound imaging, play a critical role in early disease detection, diagnosis, and treatment monitoring. The rising prevalence of cancer, genetic disorders, and the growing aging population are key factors increasing the demand for precise and early diagnostic solutions, thereby driving the expansion of the molecular imaging market globally.
Market Growth Drivers:
The global molecular imaging market is witnessing significant growth due to the increasing prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders, which require early and accurate diagnosis. The aging global population is further contributing to the demand for advanced imaging technologies, as older individuals are more susceptible to complex health conditions. Technological advancements in imaging modalities, along with the integration of artificial intelligence and hybrid imaging systems, are enhancing diagnostic accuracy and efficiency. Additionally, growing investments in healthcare infrastructure and rising awareness about early disease detection are accelerating market growth.
Market Restraints:
Despite strong growth prospects, the molecular imaging market faces several challenges, including the high cost of imaging systems and procedures, which can limit adoption in developing and cost-sensitive regions. The requirement for specialized infrastructure and skilled professionals to operate advanced imaging equipment further restricts widespread implementation. Additionally, concerns related to radiation exposure in certain imaging techniques and stringent regulatory approval processes for new imaging agents may hinder market expansion.
Market Opportunities:
The molecular imaging market offers substantial opportunities driven by ongoing research and development in imaging agents and technologies that improve precision and safety. The increasing adoption of personalized medicine is creating demand for molecular imaging in targeted therapy planning and monitoring. Emerging markets in Asia-Pacific, Latin America, and the Middle East present significant growth potential due to improving healthcare infrastructure and rising healthcare expenditure. Furthermore, collaborations between research institutes, diagnostic centers, and industry players, along with advancements in hybrid imaging systems, are expected to create new avenues for innovation and market expansion.
Key Questions Answered in the Report:
Leading companies in the global molecular imaging market are focusing on technological innovation, product development, and strategic collaborations to strengthen their market position. These companies are investing heavily in research and development to enhance imaging capabilities, reduce scan times, and improve patient safety. Partnerships with hospitals, diagnostic centers, and research institutions are helping expand their global footprint. Additionally, companies are working on integrating advanced software solutions, including AI-based imaging analysis, to improve diagnostic outcomes and gain a competitive edge.
Companies Covered in This Report:
By Modality
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Molecular Imaging Market Size (2025E): US$ 6.0 Bn
- Projected Market Value (2032F): US$ 11.9 Bn
- Global Market Growth Rate (CAGR 2025 to 2032): 10.3%
The molecular imaging market encompasses advanceed biomedical imaging techniques that enable healthcare professionals to visualize, characterize, and quantify biological processes at the cellular and molecular levels within living organisms. These technologies, including positron emission tomography (PET), single photon emission computed tomography (SPECT), and molecular ultrasound imaging, play a critical role in early disease detection, diagnosis, and treatment monitoring. The rising prevalence of cancer, genetic disorders, and the growing aging population are key factors increasing the demand for precise and early diagnostic solutions, thereby driving the expansion of the molecular imaging market globally.
Market Growth Drivers:
The global molecular imaging market is witnessing significant growth due to the increasing prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders, which require early and accurate diagnosis. The aging global population is further contributing to the demand for advanced imaging technologies, as older individuals are more susceptible to complex health conditions. Technological advancements in imaging modalities, along with the integration of artificial intelligence and hybrid imaging systems, are enhancing diagnostic accuracy and efficiency. Additionally, growing investments in healthcare infrastructure and rising awareness about early disease detection are accelerating market growth.
Market Restraints:
Despite strong growth prospects, the molecular imaging market faces several challenges, including the high cost of imaging systems and procedures, which can limit adoption in developing and cost-sensitive regions. The requirement for specialized infrastructure and skilled professionals to operate advanced imaging equipment further restricts widespread implementation. Additionally, concerns related to radiation exposure in certain imaging techniques and stringent regulatory approval processes for new imaging agents may hinder market expansion.
Market Opportunities:
The molecular imaging market offers substantial opportunities driven by ongoing research and development in imaging agents and technologies that improve precision and safety. The increasing adoption of personalized medicine is creating demand for molecular imaging in targeted therapy planning and monitoring. Emerging markets in Asia-Pacific, Latin America, and the Middle East present significant growth potential due to improving healthcare infrastructure and rising healthcare expenditure. Furthermore, collaborations between research institutes, diagnostic centers, and industry players, along with advancements in hybrid imaging systems, are expected to create new avenues for innovation and market expansion.
Key Questions Answered in the Report:
- What are the primary factors driving the global molecular imaging market's growth?
- Which regions and market segments are experiencing the highest demand for molecular imaging technologies?
- How are technological advancements influencing market dynamics?
- Who are the key players in the molecular imaging market, and what strategies are they adopting to stay competitive?
- What are the emerging trends and future projections for the global molecular imaging market?
Leading companies in the global molecular imaging market are focusing on technological innovation, product development, and strategic collaborations to strengthen their market position. These companies are investing heavily in research and development to enhance imaging capabilities, reduce scan times, and improve patient safety. Partnerships with hospitals, diagnostic centers, and research institutions are helping expand their global footprint. Additionally, companies are working on integrating advanced software solutions, including AI-based imaging analysis, to improve diagnostic outcomes and gain a competitive edge.
Companies Covered in This Report:
- Bruker
- GE HealthCare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Mediso
- Cubresa Inc.
- Shimadzu Corporation
- United Imaging Healthcare Co.
- Positron Corporation
By Modality
- Molecular Ultrasound Imaging
- Positron Emission Tomography
- Single Photon Emission Computed Tomography
- Cardiovascular
- Neurology
- Oncology
- Hospitals
- Diagnostic Imaging Centers
- Research Institutes
- North America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
198 Pages
- 1. Executive Summary
- 1.1. Global Molecular Imaging Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-economic Factors
- 2.3.1. Global Sectoral Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Tool Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 4. Price Analysis, 2024A
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Deployment Costs
- 4.3. Pricing Analysis, By Application
- 5. Global Molecular Imaging Market Outlook
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 5.3. Global Molecular Imaging Market Outlook: Modality
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Modality, 2019-2024
- 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 5.3.3.1. Molecular Ultrasound Imaging
- 5.3.3.2. Positron Emission Tomography
- 5.3.3.3. Single Photon Emission Computed Tomography
- 5.3.4. Market Attractiveness Analysis: Modality
- 5.4. Global Molecular Imaging Market Outlook: Application
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 5.4.3.1. Cardiovascular
- 5.4.3.2. Neurology
- 5.4.3.3. Oncology
- 5.4.4. Market Attractiveness Analysis: Application
- 5.5. Global Molecular Imaging Market Outlook: End-user
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
- 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 5.5.3.1. Hospitals
- 5.5.3.2. Diagnostic Imaging Centers
- 5.5.3.3. Research Institutes
- 5.5.4. Market Attractiveness Analysis: End-user
- 6. Global Molecular Imaging Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
- 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
- 7. North America Molecular Imaging Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Modality
- 7.2.3. By Application
- 7.2.4. By End-user
- 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 7.4.1. Molecular Ultrasound Imaging
- 7.4.2. Positron Emission Tomography
- 7.4.3. Single Photon Emission Computed Tomography
- 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Cardiovascular
- 7.5.2. Neurology
- 7.5.3. Oncology
- 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Diagnostic Imaging Centers
- 7.6.3. Research Institutes
- 7.7. Market Attractiveness Analysis
- 8. Europe Molecular Imaging Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Modality
- 8.2.3. By Application
- 8.2.4. By End-user
- 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
- 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 8.4.1. Molecular Ultrasound Imaging
- 8.4.2. Positron Emission Tomography
- 8.4.3. Single Photon Emission Computed Tomography
- 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.5.1. Cardiovascular
- 8.5.2. Neurology
- 8.5.3. Oncology
- 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Diagnostic Imaging Centers
- 8.6.3. Research Institutes
- 8.7. Market Attractiveness Analysis
- 9. East Asia Molecular Imaging Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Modality
- 9.2.3. By Application
- 9.2.4. By End-user
- 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 9.4.1. Molecular Ultrasound Imaging
- 9.4.2. Positron Emission Tomography
- 9.4.3. Single Photon Emission Computed Tomography
- 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Cardiovascular
- 9.5.2. Neurology
- 9.5.3. Oncology
- 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Diagnostic Imaging Centers
- 9.6.3. Research Institutes
- 9.7. Market Attractiveness Analysis
- 10. South Asia & Oceania Molecular Imaging Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Modality
- 10.2.3. By Application
- 10.2.4. By End-user
- 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
- 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 10.4.1. Molecular Ultrasound Imaging
- 10.4.2. Positron Emission Tomography
- 10.4.3. Single Photon Emission Computed Tomography
- 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Cardiovascular
- 10.5.2. Neurology
- 10.5.3. Oncology
- 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Diagnostic Imaging Centers
- 10.6.3. Research Institutes
- 10.7. Market Attractiveness Analysis
- 11. Latin America Molecular Imaging Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Modality
- 11.2.3. By Application
- 11.2.4. By End-user
- 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 11.4.1. Molecular Ultrasound Imaging
- 11.4.2. Positron Emission Tomography
- 11.4.3. Single Photon Emission Computed Tomography
- 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Cardiovascular
- 11.5.2. Neurology
- 11.5.3. Oncology
- 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Diagnostic Imaging Centers
- 11.6.3. Research Institutes
- 11.7. Market Attractiveness Analysis
- 12. Middle East & Africa Molecular Imaging Market Outlook
- 12.1. Key Highlights
- 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Modality
- 12.2.3. By Application
- 12.2.4. By End-user
- 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
- 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Modality, 2025-2032
- 12.4.1. Molecular Ultrasound Imaging
- 12.4.2. Positron Emission Tomography
- 12.4.3. Single Photon Emission Computed Tomography
- 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 12.5.1. Cardiovascular
- 12.5.2. Neurology
- 12.5.3. Oncology
- 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Diagnostic Imaging Centers
- 12.6.3. Research Institutes
- 12.7. Market Attractiveness Analysis
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2024
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Bruker
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Deployments
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. GE Healthcare
- 13.3.3. Siemens Healthineers
- 13.3.4. Koninklijke Philips N.V.
- 13.3.5. Canon Medical Systems Corporation
- 13.3.6. Mediso
- 13.3.7. Cubresa Inc.
- 13.3.8. Shimadzu Corporation
- 13.3.9. United Imaging Healthcare Co.
- 13.3.10. Positron Corporation
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
